Strong global health surveillance by the World Health Organization and CDC indicates no novel pathogens with sustained human-to-human transmission or pandemic potential are currently circulating, supporting the 89.5% market-implied probability against a new pandemic in 2026. Endemic COVID-19 variants and seasonal influenza continue at manageable levels without evidence of rapid evolution toward high-virulence strains. Recent genomic monitoring and outbreak tracking show stable epidemiological indicators, with no confirmed clusters meeting international alert thresholds. While zoonotic spillover risks persist in regions with high human-animal contact, improved early-warning systems and vaccine platforms reduce escalation likelihood. Trader consensus aligns with historical rarity of pandemics and ongoing data releases from sentinel networks expected through year-end.